These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33982328)

  • 1. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
    Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
    Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
    Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma.
    Geng X; Geng Z; Li H; Zhang Y; Li J; Chang H
    Liver Int; 2020 Jul; 40(7):1756-1769. PubMed ID: 32174027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells.
    Ma R; Gao QY; Chen ZT; Liao GH; Li ST; Cai JW; Luo NS; Chen H; Zhang HF
    Cell Cycle; 2024 Feb; 23(4):435-447. PubMed ID: 38626328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGC-1α activates SIRT3 to modulate cell proliferation and glycolytic metabolism in breast cancer.
    Zu Y; Chen XF; Li Q; Zhang ST; Si LN
    Neoplasma; 2021 Mar; 68(2):352-361. PubMed ID: 33231084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
    Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
    Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells.
    Yao G; Yin J; Wang Q; Dong R; Lu J
    Biomed Res Int; 2019; 2019():2560650. PubMed ID: 31781603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long non-coding RNA UPK1A-AS1 promotes glycolysis in hepatocellular carcinoma cells
    Zhang D; Zou X; Song Y; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Feb; 41(2):193-199. PubMed ID: 33624591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
    Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
    Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer.
    Liu B; Qu X; Wang J; Xu L; Zhang L; Xu B; Su J; Bian X
    Exp Cell Res; 2023 Apr; 425(1):113514. PubMed ID: 36804531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
    Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
    Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
    Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
    J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
    Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
    Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPLP2 activates TLR4 in an autocrine manner and promotes HIF-1α-induced metabolic reprogramming in hepatocellular carcinoma.
    Yang Q; Meng X; Chen J; Li X; Huang Y; Xiao X; Li R; Wu X
    Cell Death Discov; 2023 Dec; 9(1):440. PubMed ID: 38052785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.